Concepedia

Kenneth T. Thurn

KT

12

Publications

1.4K

Citations

12

H-Index

2007

Active since

Affiliations

University of California, San Francisco(Current)

Northwestern University

Argonne National Laboratory

Robert H. Lurie Comprehensive Cancer Center of Northwestern University

Moffitt Cancer Center

Kenneth T. Thurn is an author at University of California, San Francisco specializing in medicine, engineering, and nanomedicine.

Top concepts

Publications per year

2007–2016

12

Publications

12

A phase II study of the histone deacetylase inhibitor vorinostat combined with tamoxifen for the treatment of patients with hormone therapy-resistant breast cancer

Pamela N. Münster, Kenneth T. Thurn, Scott Thomas et al. · British Journal of Cancer · 2011 · 386 citations · Full text

Nanoparticles for Applications in Cellular Imaging

Kenneth T. Thurn, EricMB Brown, Aiguo Wu et al. · Nanoscale Research Letters · 2007 · 173 citations · Full text

, , +11

Endocytosis of titanium dioxide nanoparticles in prostate cancer PC-3M cells

Kenneth T. Thurn, Hans Arora, Tatjana Paunesku et al. · Nanomedicine Nanotechnology Biology and Medicine · 2010 · 161 citations

, , +9

Intracellular Distribution of TiO<sub>2</sub>−DNA Oligonucleotide Nanoconjugates Directed to Nucleolus and Mitochondria Indicates Sequence Specificity

Tatjana Paunesku, Stefan Vogt, Barry Lai et al. · Nano Letters · 2007 · 120 citations · Full text

, , +17

Addition of a histone deacetylase inhibitor redirects tamoxifen-treated breast cancer cells into apoptosis, which is opposed by the induction of autophagy

Scott Thomas, Kenneth T. Thurn, Elona Biçaku et al. · Breast Cancer Research and Treatment · 2011 · 111 citations · Full text

, , +8

Rows per page

1–5 of 12